114 related articles for article (PubMed ID: 34117593)
1. Treatment Patterns, Effectiveness, and Satisfaction Among Patients with Type 2 Diabetes Treated with Insulin in Saudi Arabia: Results of the RIMODIS Study.
AlSlail FY; Akil YA
Diabetes Ther; 2021 Jul; 12(7):1965-1978. PubMed ID: 34117593
[TBL] [Abstract][Full Text] [Related]
2. EADSG Guidelines: Insulin Therapy in Diabetes.
Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
[TBL] [Abstract][Full Text] [Related]
3. Oral antidiabetic medication adherence and glycaemic control among patients with type 2 diabetes mellitus: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia.
Balkhi B; Alwhaibi M; Alqahtani N; Alhawassi T; Alshammari TM; Mahmoud M; Almetwazi M; Ata S; Kamal KM
BMJ Open; 2019 Jul; 9(7):e029280. PubMed ID: 31340969
[TBL] [Abstract][Full Text] [Related]
4. Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study.
Bu S; Zhang X; Zhu H; Shuai Y; Xing X; Yang W;
Diabetes Ther; 2017 Aug; 8(4):887-898. PubMed ID: 28623551
[TBL] [Abstract][Full Text] [Related]
5. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
[TBL] [Abstract][Full Text] [Related]
6. Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study.
Jin Y; Sun X; Zhao X; Zhu T
Diabetes Ther; 2017 Jun; 8(3):611-621. PubMed ID: 28349442
[TBL] [Abstract][Full Text] [Related]
7. Effective switch from premixed to basal-prandial insulin to achieve glycemic goals in type 2 diabetes.
Lavernia F
Postgrad Med; 2010 May; 122(3):28-32. PubMed ID: 20463411
[TBL] [Abstract][Full Text] [Related]
8. Addition of Basal Insulin to Oral Antidiabetic Agents in Patients with Inadequately Controlled Type 2 Diabetes Leads to Improved HbA1c Levels: Metabolic Control, Frequency of Hypoglycemia, and Insulin Titration Analysis as Results of a Prospective Observational Study (BALI Study).
Brož J; Janíčková Ždárská D; Štěpánová R; Kvapil M
Diabetes Ther; 2019 Apr; 10(2):663-672. PubMed ID: 30788806
[TBL] [Abstract][Full Text] [Related]
9. Association of diabetic ketoacidosis, severe hypoglycemia and glycemic control among children and young adults with type 1 diabetes mellitus treated with premixed versus basal-bolus insulin therapy.
Chou WY; Li YR; Chan WK; Chen ST
Biomed J; 2018 Dec; 41(6):348-355. PubMed ID: 30709576
[TBL] [Abstract][Full Text] [Related]
10. Suboptimal glycemic control among subjects with diabetes mellitus in India: a subset analysis of cross-sectional wave-7 (2016) data from the International Diabetes Management Practices Study (IDMPS).
Ramachandran A; Jain SM; Mukherjee S; Phatak S; Pitale S; Singh SK; Agrawal N; Majumdar A; Deshpande N; Jhulka S; Minakshisundaram S; Chawla M; Lodha S; Maheshwari A; Makkar BM; Rao S; Shah P; Ghosh R; Mohanasundaram S; Menon S; Chodankar D; Kanade V; Trivedi C
Ther Adv Endocrinol Metab; 2020; 11():2042018820937217. PubMed ID: 32647562
[TBL] [Abstract][Full Text] [Related]
11. Switching from Premixed Insulin To Basal Insulin Analogue For Type 2 Diabetes and Role of Dipeptidyl Peptidase-4 Inhibitors.
Gómez-Peralta F; Abreu C; Mora-Navarro G; López-Morandeira P; Pérez-Gutierrez E; Cordero-García B; Brito-Sanfiel M
Exp Clin Endocrinol Diabetes; 2018 May; 126(5):268-276. PubMed ID: 28704854
[TBL] [Abstract][Full Text] [Related]
12. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
Ilag LL; Kerr L; Malone JK; Tan MH
Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
[TBL] [Abstract][Full Text] [Related]
13. Reported Benefits of Insulin Therapy for Better Glycemic Control in Type 2 Diabetic Patients-Is This Applicable in Saudi Patients?
AlSaggaf W; Asiri M; Ajlan B; Afif AB; Khalil R; Salman AB; Alghamdi A; Bashawieh O; Alamoudi A; Aljahdali A; Aljahdali N; Patwa H; Bakhaidar M; Bahijri SM; Ahmed M; Al-Shali K; Bokhari S; Alhozali A; Borai A; Ajabnoor G; Tuomilehto J
Clin Med Insights Endocrinol Diabetes; 2016; 9():13-7. PubMed ID: 27330334
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China.
Liu G; Dou J; Pan Y; Yan Y; Zhu H; Lu J; Gaisano H; Ji L; He Y
Front Endocrinol (Lausanne); 2018; 9():639. PubMed ID: 30420835
[No Abstract] [Full Text] [Related]
15. Insulin Management of Patients with Inadequately Controlled Type 2 Diabetes Admitted to Hospital: Titration Patterns and Frequency of Hypoglycemia as Results of a Prospective Observational Study (Hospital Study).
Brož J; Janíčková Žďárská D; Urbanová J; Piťhová P; Doničová V; Pálová S; Pelechová B; Smržová A; Kvapil M
Diabetes Ther; 2021 Jul; 12(7):1799-1808. PubMed ID: 34028699
[TBL] [Abstract][Full Text] [Related]
16. Association between self-care management practices and glycemic control of patients with type 2 diabetes mellitus in Saud Arabia: A cross -sectional study.
Alodhayani A; Almutairi KM; Vinluan JM; Almigbal TH; Alonazi WB; Ali Batais M; Mohammed Alnassar M
Saudi J Biol Sci; 2021 Apr; 28(4):2460-2465. PubMed ID: 33911959
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Human Premixed and Basal Plus Short-Acting Insulin Regimens for Individuals With Type 2 Diabetes During Ramadan Fasting.
Altemimi MT; Odhaib SA; Imran HJ; Alhamza A; Almomin A; Mansour AA
Cureus; 2020 Dec; 12(12):e11976. PubMed ID: 33425548
[TBL] [Abstract][Full Text] [Related]
18. Patterns and preferences of antidiabetic drug use in Turkish patients with type 2 diabetes - A nationwide cross-sectional study (TEMD treatment study).
Haymana C; Sonmez A; Demirci I; Fidan Yaylalı G; Nuhoglu I; Sancak S; Yilmaz M; Altuntas Y; Dinccag N; Sabuncu T; Bayram F; Satman I;
Diabetes Res Clin Pract; 2021 Jan; 171():108556. PubMed ID: 33242516
[TBL] [Abstract][Full Text] [Related]
19. Safety and effectiveness of insulin detemir in combination with oral antidiabetic agents in an outpatient specialist setting: results of the Italian SOLVE™ observational study.
Caputo S; Maran A; Mannino D; Morano S; Lastoria G; Nicoziani P
Minerva Endocrinol; 2015 Dec; 40(4):249-58. PubMed ID: 26551483
[TBL] [Abstract][Full Text] [Related]
20. A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes.
Miyoshi H; Baxter M; Kimura T; Hattori M; Morimoto Y; Marinkovich D; Tamiwa M; Hirose T
Diabetes Ther; 2021 May; 12(5):1341-1357. PubMed ID: 33730337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
